- Seed
- €22M (Oct 2026)
Rivercell is a Paris biotech founded in 2026 that runs its own wet lab to generate time-resolved single-cell data on how human cells respond to drugs and genetic edits. That data trains an AI model meant to predict the response before the experiment is run.
It came out of stealth in October 2026 with a €22 million seed round led by HV, with HCVC, Alven and Bpifrance, to expand the lab and launch its virtual cell programme.